The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While ...

UMass Lowell Recognized as Top Research Institution with R1 Classification Read More ⁠ ...

What should investors who are experiencing Nasdaq market whiplash do now? I think buying three Nasdaq stocks hand over fist and holding them for decades is a smart move.

New research highlights how the brain’s own chemistry can suppress pain, explaining why severely injured individuals, like ...

I'm especially bullish about another new drug in Vertex's lineup -- Journavx. In January, this drug became the first new class of pain medication approved by the FDA in over 20 years. Journavx ...

The encouraging result comes just days after the US FDA approved Vertex Pharma's non-opioid painkiller Journavx (suzetrigine), an oral NaV1.8 inhibitor, as a treatment for acute pain, representing ...